Endo International Plc (ENDP)

15.94
NASDAQ : Health Technology
Prev Close 15.94
Day Low/High 0.00 / 0.00
52 Wk Low/High 5.27 / 17.46
Avg Volume 5.27M
Exchange NASDAQ
Shares Outstanding 223.93M
Market Cap 3.55B
EPS -9.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Endo To Participate At Morgan Stanley Global Healthcare Conference

Endo To Participate At Morgan Stanley Global Healthcare Conference

DUBLIN, Sept. 6, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Morgan Stanley 16 th Annual Global Healthcare Conference in New York City on Wednesday,...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGN, DSS, ENDP, ICUI, PIH, SPB, SPPI, WAAS, YRD Downgrades: BMA, BRT, ELSE, FRBK, HAE, HSKA, JD, MATW, TCMD, TSG Initiations: ALT, TRTX Read on to get TheStreet Quant Ratings' detailed report:

Endo Lifts Temporary Stay Of FDA Litigation Following The Launch Of A Bulk-Compounded Vasopressin Product By A Section 503B Outsourcing Facility

Endo Lifts Temporary Stay Of FDA Litigation Following The Launch Of A Bulk-Compounded Vasopressin Product By A Section 503B Outsourcing Facility

DUBLIN, Aug. 15, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it is lifting a temporary stay of its litigation against the U.

PGA Golfer Tim Herron Teams Up With Endo Pharmaceuticals To Encourage Parents To Get Their Own Check-Ups This Back-to-School Season

PGA Golfer Tim Herron Teams Up With Endo Pharmaceuticals To Encourage Parents To Get Their Own Check-Ups This Back-to-School Season

PGA golfer Tim Herron is working with Facts on Hand  to put a spotlight on Dupuytren's Contracture, a hand condition that generally appears after age 40 and often is confused with arthritis Endo Pharmaceuticals and Herron team up to urge parents to take...

Endo Reports Second-Quarter 2018 Financial Results

Endo Reports Second-Quarter 2018 Financial Results

DUBLIN , Aug. 8, 2018 /PRNewswire/ -- Second-quarter 2018 revenues of $715 million compared to second-quarter 2017 revenues of $876 million Second-quarter 2018 XIAFLEX ® franchise revenues increased 27 percent versus second-quarter 2017 to $64 million...

Endo Announces Appointment Of Laure Park As Senior Vice President, Investor Relations And Corporate Affairs

Endo Announces Appointment Of Laure Park As Senior Vice President, Investor Relations And Corporate Affairs

DUBLIN, Aug. 2, 2018 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) announced today that it has appointed Laure Park as Senior Vice President, Investor Relations and Corporate Affairs, effective immediately.

Endo Begins Shipment Of Authorized Generic Version Of INVANZ® (ertapenem For Injection) In The United States

Endo Begins Shipment Of Authorized Generic Version Of INVANZ® (ertapenem For Injection) In The United States

DUBLIN, July 27, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's INVANZ ® (ertapenem for injection).

First Week Of September 21st Options Trading For Endo International (ENDP)

First Week Of September 21st Options Trading For Endo International (ENDP)

Investors in Endo International plc saw new options begin trading this week, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new September 21st contracts and identified one put and one call contract of particular interest.

Bioprojet And Endo Jointly Announce Agreement For Paladin Labs Inc. To Commercialize Pitolisant In Canada

Bioprojet And Endo Jointly Announce Agreement For Paladin Labs Inc. To Commercialize Pitolisant In Canada

DUBLIN, July 25, 2018 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP), announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with Bioprojet SCR to register, commercialize, and distribute pitolisant on an...

Endo To Announce Second-Quarter 2018 Financial Results

Endo To Announce Second-Quarter 2018 Financial Results

DUBLIN, July 20, 2018 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2018 financial results on August 8, 2018 and members of its senior management team will host a conference call and webcast before the U.

ENDP August 24th Options Begin Trading

ENDP August 24th Options Begin Trading

Investors in Endo International plc saw new options become available today, for the August 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new August 24th contracts and identified one put and one call contract of particular interest.

Endo Begins Shipment Of Authorized Generic Version Of Colcrys® (colchicine, USP) In The United States

Endo Begins Shipment Of Authorized Generic Version Of Colcrys® (colchicine, USP) In The United States

DUBLIN, July 2, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc.

Alibaba, Applied Materials, Chesapeake Energy: 'Mad Money' Lightning Round

Alibaba, Applied Materials, Chesapeake Energy: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Applied Materials, Chesapeake Energy, Endo Pharmaceuticals, Mylan Laboratories, JD.com, Alibaba and more.

Markets Shrug Off N. Korea: Cramer's 'Mad Money' Recap (Tuesday, June 12 2018)

Markets Shrug Off N. Korea: Cramer's 'Mad Money' Recap (Tuesday, June 12 2018)

Jim Cramer explains what U.S. markets are focusing on now that North Korean nuclear worries have faded.

Endo Announces Master Settlement Agreement Allowing For Resolution Of Known Testosterone Replacement Therapy Product Liability Claims And Entry Of Significant Case Management Order

Endo Announces Master Settlement Agreement Allowing For Resolution Of Known Testosterone Replacement Therapy Product Liability Claims And Entry Of Significant Case Management Order

DUBLIN, June 11, 2018 /PRNewswire/ -- Endo International plc (NASDAQ:  ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc.

GoPro Is Among Seven Stocks Poised for a Reversal

GoPro Is Among Seven Stocks Poised for a Reversal

These names are showing technical characteristics of either bullish or bearish reversal patterns.

HollyFrontier, Broadridge Financial Solutions Set To Join S&P 500; Others To Join S&P MidCap 400 And S&P SmallCap 600

HollyFrontier, Broadridge Financial Solutions Set To Join S&P 500; Others To Join S&P MidCap 400 And S&P SmallCap 600

NEW YORK, June 8, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range.

Noteworthy Wednesday Option Activity: ENDP, IRBT, SLCA

Noteworthy Wednesday Option Activity: ENDP, IRBT, SLCA

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Endo International plc , where a total volume of 44,854 contracts has been traded thus far today, a contract volume which is representative of approximately 4.5 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 90.8% of ENDP's average daily trading volume over the past month, of 4.9 million shares.

ENDP July 13th Options Begin Trading

Investors in Endo International plc saw new options become available today, for the July 13th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new July 13th contracts and identified the following call contract of particular interest.

A Surprise Reaction to Nvidia's Earnings Offer Up One Important Investing Lesson

A Surprise Reaction to Nvidia's Earnings Offer Up One Important Investing Lesson

It has been yet another long week on Wall Street. On Friday, investors are greeted with a mild Nvidia earnings related selloff. Be on the lookout for valuation-based tech stock downgrades in the week ahead.

What to Expect From Trump's Speech on Drug Prices on Friday

What to Expect From Trump's Speech on Drug Prices on Friday

Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.

June 8th Options Now Available For Endo International (ENDP)

Investors in Endo International plc saw new options begin trading today, for the June 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new June 8th contracts and identified one put and one call contract of particular interest.

Interesting ENDP Put And Call Options For June 15th

Investors in Endo International plc saw new options begin trading this week, for the June 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new June 15th contracts and identified one put and one call contract of particular interest.

Mylan's Stock Gets Bump After Investor Day

Mylan's Stock Gets Bump After Investor Day

Following Wednesday's event, Leerink analyst Ami Fadia said she is 'incrementally more positive' on the drugmaker's pipeline and diversified business model and moved her rating to outperform.

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.

TheStreet Quant Rating: C- (Hold)